Related Experiment Video
Updated: May 12, 2026
04:48
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Molecular level activation insights from a NR2A/NR2B agonist
Weng Ieong Tou1, Su-Sen Chang, Dongchuan Wu
1a School of Medicine, College of Medicine , China Medical University , Taichung , 40402 , Taiwan .
Journal of Biomolecular Structure & Dynamics
|April 23, 2013
Summary
Alliin, a compound in garlic, binds to specific N-methyl D-aspartate receptors (NMDARs), potentially preventing excitotoxicity. This discovery offers new avenues for developing stroke treatments by targeting these receptors.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- N-methyl D-aspartate receptors (NMDARs) are crucial for neural transmission but their overactivation causes excitotoxicity, a key factor in stroke-induced neuronal death.
- Developing drugs to modulate NMDARs is a significant research focus for treating neurological disorders, especially stroke.
Purpose of the Study:
- To investigate the potential of Alliin, a garlic compound, as a modulator of NMDARs, specifically the NR2A and NR2B subunits.
- To elucidate the molecular mechanisms underlying Alliin's interaction with NR2A and NR2B subunits.
Main Methods:
- Virtual screening was employed to identify Alliin's affinity for NR2A and NR2B receptors.
- Electrophysiological studies confirmed the biological activity of Alliin on these receptor subtypes.
- Molecular dynamics simulations were performed to analyze structural changes induced by Alliin binding.
Main Results:
- Alliin demonstrated affinity for both NR2A and NR2B NMDAR subunits.
- Electrophysiological data confirmed Alliin's biological activity on these receptors.
- Molecular dynamics simulations revealed that Alliin binding induces ligand-binding site closure, preventing ion channel opening, with key residues identified.
Conclusions:
- Alliin interacts with NR2A and NR2B subunits of NMDARs, inducing a unique conformational change distinct from glutamate.
- These findings provide valuable insights into the structural basis for selective NMDAR modulation.
- Alliin's interaction mechanism offers a potential therapeutic strategy for developing novel drugs targeting neurological diseases like stroke.
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
02:36RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...